They also showed that the small-molecule XIAP antagonist 1396-12 might induce cell death in cultured primary DLBCL cells by relieving caspase-3 inhibition and constitutive caspase-9 activation [27]. This evidence concerns the gene CASP3 and diffuse large B-cell lymphoma.